VEGFB and Stroke: Our earlier report of increased VEGF in the ischemic hemisphere of candesartan treated animals [5], reflected the inability of the nonspecific ELISA assay to differentiate between VEGFA and VEGFB and is a more common way to report VEGF quantification in the stroke literature.